Skip to main content
SpringerLink
Log in

The effect of agomelatine on 5HT2C receptors in humans: a clinically relevant mechanism?

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bertaina-Anglade V, Drieu C, Boyer PA, Mocaer E (2006) Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model. Behav Pharmacol 17:703–713

    Article  PubMed  CAS  Google Scholar 

  • Chagraoui A, Protais P, Filloux T, Mocaer E (2003) Agomelatine (S20098) antagonises the penile erections induced by the stimulation of 5HT2C receptors in Wistar rats. Psychopharmacology 170:17–22

    Article  PubMed  CAS  Google Scholar 

  • De Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P et al (2010) Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 9:628–642

    PubMed  Google Scholar 

  • Leproult R, Van Onderbergen A, L’Hermite-Baleriaux M, Van Cauter E, Copinschi G (2005) Phase-shifts of the 24-hr rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol 63:298–304

    Article  CAS  Google Scholar 

  • Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet J-M, Cussac D (2003) The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharm Exp Ther 306:954–964

    Article  CAS  Google Scholar 

  • Molteni R, Calabrese F, Pisoni S, Gabriel C, Mocaer E, Racagni G, Riva MA (2010) Synergistic mechanisms in the modulation of the neurotrophic BDNF in the rat prefrontal cortex following acute agomelatine administration World J Biol Psychiatry 11:148–153

    Google Scholar 

  • Norman TR, Cranston I, Irons JA, Gabriel C, Dekeyne A, Millan MJ, Mocaër E (2012) Agomelatine suppresses locomotor hyperactivity in olfactory bulbectomised rats: a comparison to melatonin and to the 5-HT2C antagonist, S32006. Eur J Pharmacol 674:27–32

    Article  PubMed  CAS  Google Scholar 

  • Quera Salva M-A, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C (2007) Major depressive disorder, sleep EEG and agomelatine: an open label study. Int J Neuropsychopharmacol 10:691–696

    PubMed  CAS  Google Scholar 

  • Sharpley AL, Rawlings NB, Brain S, McTavish SFB, Cowen PJ (2011) Does agomelatine block 5HT2C receptors in humans? Psychopharmacology 213:653–655

    Article  PubMed  CAS  Google Scholar 

  • Papp M, Gruca P, Boyer P-A, Mocaer E (2003) Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28:694–703

    Article  PubMed  CAS  Google Scholar 

  • Saitou K, Kankeo Y, Sugimoto Y, Chen Z, Kamei C (1999) Slow wave inducing effects of first generation H1-antagonists. Biol Pharm Bull 22:1079–1082

    Article  PubMed  CAS  Google Scholar 

  • Thakkar M (2011) Histamine in the regulation of wakefulness. Sleep Med Rev 15:65–74

    Article  PubMed  Google Scholar 

  • Tokunaga S, Takeda Y, Shinomiya K, Hirase M, Kamei C (2007) Effects of some H1-antagonists on the sleep–wake cycle in sleep-disturbed rats. J Pharmacol Sci 103:201–206

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The author has received research and travel funds as well as speaker fees from Servier.

Author information

Authors and Affiliations

  1. Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, 3084, Victoria, Australia

    Trevor R. Norman

Authors
  1. Trevor R. Norman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Trevor R. Norman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Norman, T.R. The effect of agomelatine on 5HT2C receptors in humans: a clinically relevant mechanism?. Psychopharmacology 221, 177–178 (2012). https://doi.org/10.1007/s00213-012-2656-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-012-2656-6

Keywords

Search

Navigation